MediciNova (NASDAQ:MNOV) shares jumped after FDA 'fast track' designation for methamphetamine-addiction drug candidate. We recommend holding tight. The company is planning to issue new common stock: we recommend buying MNOV's diluted shares after the new stock is issued. Read more
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.